Imp,
At Capricor, he is on the SAB.
Not a problem in my opinion.
At ANP - he would be Principle Investigator.
Different technologies.
I mean - he is a KOL for ANP and was on the investor roadshow when P2B results dropped...BUT...he is also patent owner of micro-dystrophin Sarepta is using.
Its all about the DMD boys - the sooner the industry gets a solution the better.
.
Imp, At Capricor, he is on the SAB. Not a problem in my opinion....
Add PER (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
6.4¢ |
Change
-0.010(13.5%) |
Mkt cap ! $57.69M | |||
| Open | High | Low | Value | Volume |
| 7.4¢ | 7.6¢ | 5.9¢ | $516.4K | 8.992M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 339429 | 6.4¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 7.6¢ | 143169 | 1 |
View Market Depth
| Last trade - 16.10pm 25/04/2024 (20 minute delay) ? |
|
|||||
|
Last
5.9¢ |
Change
-0.010 ( 21.3 %) |
||||
| Open | High | Low | Volume | ||
| 7.6¢ | 7.6¢ | 5.9¢ | 132018 | ||
| Last updated 15.49pm 25/04/2024 ? | |||||
| PER (ASX) Chart |